Analyze Diet
The Veterinary record1993; 133(24); 594-597;

Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992).

Abstract: The records of 21 horses with an adenoma of the pars intermedia of the pituitary gland were reviewed. The animals comprised nine Dutch warmblood horses and 12 ponies. They ranged in age from 12 to 30 years (mean +/- sem 21 +/- 1.3 years) for 20 of the horses, and comprised 13 geldings and eight mares. All the animals showed hirsutism. In 1991, nine horses were diagnosed as having the adenoma, equivalent to 0.5 per cent of the horses examined in 1991. The mean +/- sem survival time of four of the horses (from discharge to the development of complications which required euthanasia) was 192 +/- 59 days (range 120 to 368 days). Routine biochemical measurements were within their normal ranges except for a high alkaline phosphatase activity (768 +/- 487 iu/litre) and a high plasma glucose concentration (7.8 +/- 0.9 mmol/litre) in 16 of the horses; only six had a glucose concentration above 9.0 mmol/litre. The basal plasma concentration of adrenocorticotrophic hormone (ACTH) in the diseased horses was at least 191 pg/ml. Eight of the horses had mean plasma cortisol concentrations before and after the administration of 25 iu of synthetic ACTH1-24 of 168 +/- 21 (range 74 to 248) and 478 +/- 58 nmol/litre (range 248 to 771), respectively. Analysis of the urine of five of the horses revealed a mean specific gravity of 1.034 +/- 0.0034 (range 1.025 to 1.045).(ABSTRACT TRUNCATED AT 250 WORDS)
Publication Date: 1993-12-11 PubMed ID: 8116170
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research is a retrospective study on 21 horses affected by pituitary adenomas, examining their clinical, biochemical, and endocrinological characteristics.

Introduction to the Study

  • The study involves a review of medical records of 21 horses affected by an adenoma (a type of tumor) in the pars intermedia of their pituitary glands.
  • This selection consists of both Dutch warmblood horses and ponies, with ages ranging from 12 to 30 years.

Patient Characteristics

  • The sample group of animals comprises 13 geldings (neutered male horses) and eight mares.
  • One common symptom observed in all of these animals was hirsutism, a condition characterized by excessive hair growth.

Disease Prevalence and Survival Time

  • In the year 1991, out of the total horses examined, 0.5% were diagnosed with this condition.
  • Of the total cases, four horses were tracked from the time of discharge to the point when they developed severe complications that necessitated euthanasia. Their mean survival time was about 192 days.

Biochemical Measurements

  • Standard biochemical measurements for these horses were mostly within the standard ranges. However, elevated levels of alkaline phosphatase and a high plasma glucose concentration were detected in some horses.

Endocrine Measurements

  • The basal plasma concentration of Adrenocorticotropic hormone (ACTH), which plays a crucial role in stress response, was recorded to be significantly high in the diseased horses.
  • Additionally, cortisol concentrations were measured before and after the administration of a synthetic ACTH. The mean cortisol levels rose noticeably post-administration, suggesting adrenal hyperactivity, a common feature in this type of pituitary disease.

Urine Analysis

  • The urine of five horses was analyzed. The mean specific gravity, which is a test to check kidney function, was slightly higher than the typical range.

The article’s abstract ends here, being truncated at 250 words. It is essentially an exploration into a specific type of equine pituitary disease, presenting insights into its prevalence, associated symptoms, and physiological impact.

Cite This Article

APA
van der Kolk JH, Kalsbeek HC, van Garderen E, Wensing T, Breukink HJ. (1993). Equine pituitary neoplasia: a clinical report of 21 cases (1990-1992). Vet Rec, 133(24), 594-597.

Publication

ISSN: 0042-4900
NlmUniqueID: 0031164
Country: England
Language: English
Volume: 133
Issue: 24
Pages: 594-597

Researcher Affiliations

van der Kolk, J H
  • Department of Large Animal Medicine and Nutrition, Veterinary Faculty, Utrecht University, The Netherlands.
Kalsbeek, H C
    van Garderen, E
      Wensing, T
        Breukink, H J

          MeSH Terms

          • Adenoma / blood
          • Adenoma / pathology
          • Adenoma / veterinary
          • Animals
          • Female
          • Horse Diseases / blood
          • Horse Diseases / pathology
          • Horses
          • Male
          • Pituitary Gland, Posterior / pathology
          • Pituitary Neoplasms / blood
          • Pituitary Neoplasms / pathology
          • Pituitary Neoplasms / veterinary
          • Survival Rate

          Citations

          This article has been cited 9 times.
          1. Vaughn SA, Lemons MB, Hart KA. The Effect of Season and Breed on Hypothalamic-Pituitary-Adrenal Axis Hormones, Metabolic Hormones, and Oxidative Markers in Ponies and Horses. J Vet Intern Med 2025 Mar-Apr;39(2):e70047.
            doi: 10.1111/jvim.70047pubmed: 40048369google scholar: lookup
          2. de Preux M, Precht C, Guevar J, Graubner C, Thenhaus-Schnabel S, Buser L, Lukes A, Koch C. A transmandibular lateral transsphenoidal navigated surgical approach to access a pituitary macroadenoma in a warmblood mare. Vet Q 2024 Dec;44(1):1-10.
            doi: 10.1080/01652176.2023.2300947pubmed: 38393300google scholar: lookup
          3. Stoeckle SD, Timmermann D, Merle R, Gehlen H. Plasma Amino Acids in Horses Suffering from Pituitary Pars Intermedia Dysfunction. Animals (Basel) 2022 Nov 27;12(23).
            doi: 10.3390/ani12233315pubmed: 36496836google scholar: lookup
          4. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses. Vet Sci 2022 Oct 10;9(10).
            doi: 10.3390/vetsci9100556pubmed: 36288169google scholar: lookup
          5. Fortin JS, Hetak AA, Duggan KE, Burglass CM, Penticoff HB, Schott HC 2nd. Equine pituitary pars intermedia dysfunction: a spontaneous model of synucleinopathy. Sci Rep 2021 Aug 6;11(1):16036.
            doi: 10.1038/s41598-021-95396-7pubmed: 34362943google scholar: lookup
          6. Fortin JS, Benskey MJ, Lookingland KJ, Patterson JS, Howey EB, Goudreau JL, Schott HC 2nd. Restoring pars intermedia dopamine concentrations and tyrosine hydroxylase expression levels with pergolide: evidence from horses with pituitary pars intermedia dysfunction. BMC Vet Res 2020 Sep 25;16(1):356.
            doi: 10.1186/s12917-020-02565-3pubmed: 32977825google scholar: lookup
          7. Morgan RA, Keen JA, Homer N, Nixon M, McKinnon-Garvin AM, Moses-Williams JA, Davis SR, Hadoke PWF, Walker BR. Dysregulation of Cortisol Metabolism in Equine Pituitary Pars Intermedia Dysfunction. Endocrinology 2018 Nov 1;159(11):3791-3800.
            doi: 10.1210/en.2018-00726pubmed: 30289445google scholar: lookup
          8. Spelta CW. Equine pituitary pars intermedia dysfunction: current perspectives on diagnosis and management. Vet Med (Auckl) 2015;6:293-300.
            doi: 10.2147/VMRR.S74191pubmed: 30101114google scholar: lookup
          9. Carmalt JL, Waldner CL, Allen AL. Equine pituitary pars intermedia dysfunction: An international survey of veterinarians' approach to diagnosis, management, and estimated prevalence. Can J Vet Res 2017 Oct;81(4):261-269.
            pubmed: 29081583